PRNewsWire
24 Sept 2026, 21:39 UTC · 1h ago
Verdict
Headline leans bearish. We score CAPR −1.00 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−1.00strongly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
An FDA advisory committee voted 9-3 on July 29, 2026, that available evidence does not support the efficacy of deramiocel for DMD-associated cardiomyopathy.
Priced inevents occurred July 29-30, 2026
More negative than 99% of claims this week
The FDA rejected Capricor's post-study statistical analysis plan (SAP) as 'post-hoc and exploratory,' stating the benefit-risk assessment appears unfavorable.
Continue reading
5 related stories
More negative than 95% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More negative than 98% of claims this week
Pomerantz LLP has filed a class action lawsuit against Capricor Therapeutics alleging securities fraud and unlawful business practices.
Newpress release dated Sep 24, 2026
More negative than 78% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a class action lawsuit following an unfavorable FDA assessment and a significant stock price crash.
More negative than 85% of ticker scores this week
The company is the subject of a newly announced class action lawsuit.
More negative than 85% of ticker scores this week
The company is the subject of a newly announced class action lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
CAPR hasn't traded since this ran. Last close $8.57 (Sep 24); the reaction starts at the next open.
CAPR chart →
